Company: CLX
Filing Date: 2025-08-08
Form Type: 10-K
Source: 0000021076-25-000039
Chunk: 0

Company: CLOROX CO /DE/
Filing Date: 2025-08-08
Form: 10-K
Item: Item 15
Chunk 0
---
Table of Contents    

PART IV

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

(a)Financial Statements and Schedules:

    Consolidated Financial Statements and Reports of Independent Registered Public Accounting Firm included in Exhibit 99.1, incorporated herein by reference.

    Reports of Ernst & Young, LLP, Independent Registered Public Accounting Firm (PCAOB ID: 42).

    Consolidated Statements of Earnings for the fiscal years ended June 30, 2025, 2024 and 2023.

    Consolidated Statements of Comprehensive Income for the fiscal years ended June 30, 2025, 2024 and 2023.

    Consolidated Balance Sheets as of June 30, 2025 and 2024.

    Consolidated Statements of Stockholders’ Equity for the fiscal years ended June 30, 2025, 2024 and 2023.

    Consolidated Statements of Cash Flows for the fiscal years ended June 30, 2025, 2024 and 2023.

    Notes to Consolidated Financial Statements.

(b)Exhibits:

INDEX TO EXHIBITS

Incorporated by ReferenceExhibitNumberExhibit DescriptionFormFile No.ExhibitFiling Date3.1Restated Certificate of Incorporation.10-K001-071513.1August 14, 20183.2Bylaws (amended and restated).8-K001-071513.2May 23, 20253.3Certificate of Designations for The Clorox Company Series A Junior Participating Preferred Stock.8-K001-071513.1July 19, 20114.1Indenture, dated as of October 9, 2007, between the Company and The Bank of New York Trust Company N.A., as trustee.S-3ASR333-2007224.1December 4, 20144.2Fourth Supplemental Indenture, dated as of September 13, 2012, between the Company and Wells Fargo Bank, National Association, as trustee.S-3ASR333-2007224.5December 4, 20144.3Fifth Supplemental Indenture, dated as of December 9, 2014, between the Company and Wells Fargo Bank, National Association, as trustee.8-K001-071514.1December 9, 20144.